RFX7
protein-codingregulatory factor X7, the group of Regulatory factor X family
Gene summary
RFX7 is a member of the regulatory factor X (RFX) family of transcription factors (see RFX1, MIM 600006) (Aftab et al., 2008 [PubMed 18673564]).[supplied by OMIM, Mar 2009]
- RFXDC2
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~157.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0957228
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: ClinGen
Although a *de novo* protein truncating variant in *RFX7* was reported in an individual with autism spectrum disorder (ASD) as early as 2014 (PMID: 25363760), the first report focusing on variants in *RFX7* in relation to autosomal dominant complex neurodevelopmental disorder was published in 2021 (Harris et al., PMID: 33658631). *RFX7* encodes a member of the regulatory factor X (RFX) family of genes that act as master regulators of central nervous system development and ciliogenesis. Seven unique *de* *novo* variants (3 nonsense, 4 frameshift) reported in 7 probands in 2 publications (PMIDs: 25363760, 33658631) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. All reported variants are *de* *novo*, and the mechanism of disease is suggested to be haploinsufficiency (PMID: 33658631). *RFX7* is highly constrained for loss-of-function variants (pLI = 1), but not missense variants (Z = 2.02, gnomAD v4.1.0). There are a limited number of probands with detailed phenotypic features reported. Of those cases, affected individuals present with motor and speech delays, and intellectual disability; other variable features include ASD, attention deficit hyperactivity disorder, behavioral abnormalities, dysmorphic features, micro/macrocephaly, and sensory hypersensitivity (PMID: 33658631). This gene-disease relationship is also supported by experimental evidence demonstrating that individuals with variants in other RFX genes (*RFX3* and *RFX4*) have been reported with global developmental delay, intellectual disability and ASD (PMID: 33658631). In summary, there is definitive evidence supporting the relationship between *RFX7* and autosomal dominant complex neurodevelopmental disorder. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on May 15, 2024 (SOP Version 11).
Inheritance Pattern: AD
Disease ID:MONDO:0957228
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0957228
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to RFX7 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_022841.7. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 16 | 2 | 20 | ||
| missense | 1 | 3 | 254 | 59 | 2 | 319 |
| nonsense | 2 | 3 | 5 | 10 | ||
| start loss | 0 | |||||
| frameshift | 2 | 10 | 11 | 23 | ||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 5 | 16 | 273 | 75 | 4 | 373 |
Highest pathogenic variant AF is 0.0000012393017
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_073752.6 | 9 | MANE Select | |
| Ensembl | ENSP00000453281.3 | 9 | MANE Select | |
| RefSeq | NP_001355002.1 | 6 | Standard | |
| RefSeq | NP_001355003.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- regulation of transcription by RNA polymerase II
Molecular Function
- RNA polymerase II proximal promoter sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
Cellular Component
- nucleus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000423270
- Coding exons
- 9
- Length
- 156006
- Individuals with no LoFs
- 124622
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 7
- Defined
- 124629
- p
- 0.0000281
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.60 | 637 | 761 | 0.837 | 0.0000388 | 9587 |
| Missense (PolyPhen) | 201 | 328.1 | 0.61262 | 4112 | ||
| Synonymous | -0.252 | 280 | 275 | 1.02 | 0.0000143 | 2908 |
| Loss of Function | 6.13 | 2 | 47.6 | 0.0420 | 0.00000234 | 601 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00019 | 0.00017 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000035 | 0.000035 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.103
Essentials
- Essential (CRISPR2)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.488
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |